STEPHANIE SHORT: Open Payments
NPI 1780333724 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,183 in 44 payments from 15 companies in 2025. Trend: 2023 $1,377 · 2024 $1,038 · 2025 $1,183
Food & beverage: $1,183
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 7 | $258 |
| Merck Sharp & Dohme LLC | 9 | $155 |
| Novo Nordisk Inc | 1 | $122 |
| ABIOMED | 3 | $118 |
| PFIZER INC. | 4 | $83 |
| E.R. Squibb & Sons, L.L.C. | 4 | $76 |
| Alnylam Pharmaceuticals Inc. | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| BridgeBio Pharma, Inc. | 2 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
Products named: VERQUVO, Wegovy, CAMZYOS, Remodulin, ONPATTRO, Tyvaso, VYNDAQEL, Attruby.
Industry payments across OK — which companies pay providers there.
